BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 24962355)

  • 1. RNA sequencing of creatine transporter (SLC6A8) deficient fibroblasts reveals impairment of the extracellular matrix.
    Nota B; Ndika JD; van de Kamp JM; Kanhai WA; van Dooren SJ; van de Wiel MA; Pals G; Salomons GS
    Hum Mutat; 2014 Sep; 35(9):1128-35. PubMed ID: 24962355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional assessment of creatine transporter in control and X-linked SLC6A8-deficient fibroblasts.
    Joncquel-Chevalier Curt M; Bout MA; Fontaine M; Kim I; Huet G; Bekri S; Morin G; Moortgat S; Moerman A; Cuisset JM; Cheillan D; Vamecq J
    Mol Genet Metab; 2018 Apr; 123(4):463-471. PubMed ID: 29478817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of a novel intragenic rearrangement in the creatine transporter gene by next generation sequencing.
    Yu H; van Karnebeek C; Sinclair G; Hill A; Cui H; Zhang VW; Wong LJ
    Mol Genet Metab; 2013 Dec; 110(4):465-71. PubMed ID: 24140398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive deficits and increases in creatine precursors in a brain-specific knockout of the creatine transporter gene Slc6a8.
    Udobi KC; Kokenge AN; Hautman ER; Ullio G; Coene J; Williams MT; Vorhees CV; Mabondzo A; Skelton MR
    Genes Brain Behav; 2018 Jul; 17(6):e12461. PubMed ID: 29384270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotype and genotype in 101 males with X-linked creatine transporter deficiency.
    van de Kamp JM; Betsalel OT; Mercimek-Mahmutoglu S; Abulhoul L; Grünewald S; Anselm I; Azzouz H; Bratkovic D; de Brouwer A; Hamel B; Kleefstra T; Yntema H; Campistol J; Vilaseca MA; Cheillan D; D'Hooghe M; Diogo L; Garcia P; Valongo C; Fonseca M; Frints S; Wilcken B; von der Haar S; Meijers-Heijboer HE; Hofstede F; Johnson D; Kant SG; Lion-Francois L; Pitelet G; Longo N; Maat-Kievit JA; Monteiro JP; Munnich A; Muntau AC; Nassogne MC; Osaka H; Ounap K; Pinard JM; Quijano-Roy S; Poggenburg I; Poplawski N; Abdul-Rahman O; Ribes A; Arias A; Yaplito-Lee J; Schulze A; Schwartz CE; Schwenger S; Soares G; Sznajer Y; Valayannopoulos V; Van Esch H; Waltz S; Wamelink MM; Pouwels PJ; Errami A; van der Knaap MS; Jakobs C; Mancini GM; Salomons GS
    J Med Genet; 2013 Jul; 50(7):463-72. PubMed ID: 23644449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is low serum creatine kinase a nonspecific screening marker for creatine deficiency syndromes?
    Mercimek-Mahmutoglu S; Al-Thihli K; Roland E
    Mol Genet Metab; 2012 Jun; 106(2):251-2. PubMed ID: 22551696
    [No Abstract]   [Full Text] [Related]  

  • 7. Classification of the Molecular Defects Associated with Pathogenic Variants of the
    Salazar MD; Zelt NB; Saldivar R; Kuntz CP; Chen S; Penn WD; Bonneau R; Koehler Leman J; Schlebach JP
    Biochemistry; 2020 Apr; 59(13):1367-1377. PubMed ID: 32207963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimated carrier frequency of creatine transporter deficiency in females in the general population using functional characterization of novel missense variants in the SLC6A8 gene.
    DesRoches CL; Patel J; Wang P; Minassian B; Salomons GS; Marshall CR; Mercimek-Mahmutoglu S
    Gene; 2015 Jul; 565(2):187-91. PubMed ID: 25861866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical, molecular, and clinical diagnoses of patients with cerebral creatine deficiency syndromes.
    Comeaux MS; Wang J; Wang G; Kleppe S; Zhang VW; Schmitt ES; Craigen WJ; Renaud D; Sun Q; Wong LJ
    Mol Genet Metab; 2013 Jul; 109(3):260-8. PubMed ID: 23660394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of wild-type creatine transporter (SLC6A8) restores creatine uptake in primary SLC6A8-deficient fibroblasts.
    Rosenberg EH; Muñoz CM; Degrauw TJ; Jakobs Cn; Salomons GS
    J Inherit Metab Dis; 2006; 29(2-3):345-6. PubMed ID: 16763899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining the pathogenicity of creatine deficiency syndrome.
    Alcaide P; Merinero B; Ruiz-Sala P; Richard E; Navarrete R; Arias A; Ribes A; Artuch R; Campistol J; Ugarte M; Rodríguez-Pombo P
    Hum Mutat; 2011 Mar; 32(3):282-91. PubMed ID: 21140503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Creatine synthesis and exchanges between brain cells: What can be learned from human creatine deficiencies and various experimental models?
    Hanna-El-Daher L; Braissant O
    Amino Acids; 2016 Aug; 48(8):1877-95. PubMed ID: 26861125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Creatine biosynthesis and transport in health and disease.
    Joncquel-Chevalier Curt M; Voicu PM; Fontaine M; Dessein AF; Porchet N; Mention-Mulliez K; Dobbelaere D; Soto-Ares G; Cheillan D; Vamecq J
    Biochimie; 2015 Dec; 119():146-65. PubMed ID: 26542286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel SLC6A8 mutation associated with intellectual disabilities in a Chinese family exhibiting creatine transporter deficiency: case report.
    Wang Q; Yang J; Liu Y; Li X; Luo F; Xie J
    BMC Med Genet; 2018 Nov; 19(1):193. PubMed ID: 30400883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral creatine deficiencies: a group of treatable intellectual developmental disorders.
    Stockler-Ipsiroglu S; van Karnebeek CD
    Semin Neurol; 2014 Jul; 34(3):350-6. PubMed ID: 25192512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of the Creatine Transporter (Slc6a8) in Dopaminergic Neurons Leads to Hyperactivity in Mice.
    Abdulla ZI; Pahlevani B; Lundgren KH; Pennington JL; Udobi KC; Seroogy KB; Skelton MR
    J Mol Neurosci; 2020 Jan; 70(1):102-111. PubMed ID: 31520365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variable White Matter Atrophy and Intellectual Development in a Family With X-linked Creatine Transporter Deficiency Despite Genotypic Homogeneity.
    Heussinger N; Saake M; Mennecke A; Dörr HG; Trollmann R
    Pediatr Neurol; 2017 Feb; 67():45-52. PubMed ID: 28065824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ClinGen variant curation expert panel recommendations for classification of variants in GAMT, GATM and SLC6A8 for cerebral creatine deficiency syndromes.
    Goldstein J; Thomas-Wilson A; Groopman E; Aggarwal V; Bianconi S; Fernandez R; Hart K; Longo N; Liang N; Reich D; Wallis H; Weaver M; Young S; Mercimek-Andrews S
    Mol Genet Metab; 2024 May; 142(1):108362. PubMed ID: 38452609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mouse model for creatine transporter deficiency reveals early onset cognitive impairment and neuropathology associated with brain aging.
    Baroncelli L; Molinaro A; Cacciante F; Alessandrì MG; Napoli D; Putignano E; Tola J; Leuzzi V; Cioni G; Pizzorusso T
    Hum Mol Genet; 2016 Oct; 25(19):4186-4200. PubMed ID: 27466184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new rat model of creatine transporter deficiency reveals behavioral disorder and altered brain metabolism.
    Duran-Trio L; Fernandes-Pires G; Simicic D; Grosse J; Roux-Petronelli C; Bruce SJ; Binz PA; Sandi C; Cudalbu C; Braissant O
    Sci Rep; 2021 Jan; 11(1):1636. PubMed ID: 33452333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.